CVS Health Corp. buy JPMorgan Chase & Co.
Summary
This prediction ended on 31.05.25 with a price of €55.89. With a performance of 8.42%, the BUY prediction by JPMorgan_Chase___Co_ for CVS Health Corp. closed with a slight gain. JPMorgan_Chase___Co_ has a follow-up prediction for CVS Health Corp. where he still thinks CVS Health Corp. is a Buy. A total of €1.86 was paid as dividends for this prediction. JPMorgan_Chase___Co_ has 50% into this predictionCVS Health (symbol CVS) is a health care company that operates a retail pharmacy chain and offers health care services. The company is headquartered in Rhode Island, USA and has more than 9,900 locations. CVS Health operates three business segments: Pharmacy Services, Retail/LTC and Health Care Benefits. The Pharmacy Services segment offers pharmacy benefit management solutions and includes CVS Caremark, which serves more than 94 million plan members. The Retail/LTC segment operates CVS Pharmacy, the largest pharmacy chain in the United States, and provides long-term care pharmacy services through Omnicare. The Health Care Benefits segment offers a range of health insurance products and services through Aetna, which was acquired by CVS Health in 2018.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| CVS Health Corp. | -7.078% | -7.078% | -1.288% |
| iShares Core DAX® | -3.509% | -8.747% | -0.997% |
| iShares Nasdaq 100 | -2.782% | -0.632% | 14.223% |
| iShares Nikkei 225® | -2.038% | -6.841% | 24.866% |
| iShares S&P 500 | -2.598% | -2.230% | 9.200% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread CVS Health Corp. diskutieren
In the thread Trading CVS Health Corp.